2014 Congress Programme
The programme included presentations from influential industry, government, and academic representatives, and leading consultants. Sessions covered mainstream agrochemical and biopesticide regulatory activities, relevant developments in human and environmental health, current regulatory “hotspots” (yes, including updates on pollinator issues!) and reflections on balancing risk, precaution and innovation.
29 September Tour of Brighton – 16:30 – 18:00 Pre-event Welcome Drinks Reception to be held at the Hilton Metropole Hotel, Brighton – 18:00 – 19:00 (Sponsor – Eurofins Agroscience Services Limited) |
|||
Registration: 07:00 – 08:45, Conference starts: 09:00 | |||
Day 1 – 30 September | |||
PLENARY 09.00 – 10.00 Chair: Dr. Colin Ruscoe, BCPC The Precautionary Principle – is EU Innovation Losing Out? Dr. Peter Maienfisch, Syngenta Crop Protection |
|||
Break 10.00 – 10.30 | |||
Stream A (Regulatory) Chair: Lucy Croucher, JSC International Limited |
Stream B (Biopesticides) Chair: William Dunham, DunhamTrimmer LLC |
||
10.30 – 11.00 | Overview of progress in the regulation of plant protection products – industry view Aurélie Dhaussy, European Crop Protection Association, aisbl |
10.30 – 11.00 | Developing biopesticides in an increasingly challenging regulatory environment Dr. Alison Stewart, Marrone Bio Innovations |
11.00 – 11.30 | Overview of progress in the regulation of plant protection products – Member State view Gordon Rennick, Pesticide Registration & Control Division, Department of Agriculture, Food and the Marine, Ireland |
11.00 – 11.30 | Role of microbial pesticides in the multinational portfolio William Dunham, DunhamTrimmer LLC |
11.30 – 12.00 | Overview of progress in the regulation of plant protection products – the Grower’s view Don Pendergrast, National Farmers Union |
11.30 – 12.00 | A brighter future for plant derived pesticides from a regulatory perspective? Dr. Roma Gwynn, Rationale Limited |
12.00 – 12.15 | Q&A | 12.00 – 12.15 | Q&A |
Lunch 12.15 – 13.30 | |||
Stream A (Regulatory) Chair: Rob Mason, Exponent International Limited |
Stream B (Environmental science) Chair: Mike Coulson, Syngenta Ltd |
||
13.30 – 14.00 | Overview of zonal authorisation Tracy Roberts, Chemicals Regulation Directorate, Health and Safety Executive |
13.30 – 14.00 | Neonicotinoids and bees – where are we now? Mike Coulson, Syngenta Ltd |
14.00 – 14.30 | Work of the Central Zone Steering Committee Dr. Annette E. Smits-van Prooije, Ctgb |
14.00 – 14.30 | Endocrine Disruption: hazard and risk Dr. James Wheeler, Dow AgroSciences |
Break 14.30 – 15.00 | |||
15.00 – 15.50 | Regulatory panel open debate Chaired by Steve Dobson, TSGE Consulting |
15.00 – 15.50 | TOPPS-Prowadis Best Management Practices and risk mitigation tools Dr. Inge Mestdagh, Dow AgroSciences (15:00 – 15:30) Followed by Q&A (15:30 – 15:50) |
PLENARY 16.00 – 16.30 Chair: Dr. Colin Ruscoe, BCPCA new way forward, balancing precautionary and innovation principles Paul Leonard, BASF Group |
|||
![]() Sarah Shore (Head of Biocides, Pesticides and Environment), Chemicals Regulation Directorate (CRD), Health and Safety Executive |
|||
Evening of 30 September Congress Dinner to be held at the Mercure Brighton Seafront Hotel – 19:30 (dinner to be served from 20:00) (Sponsor – APC) |
|||
Day 2 – 1 October | |||
Registration: 08:00 – 08:45, Conference starts: 09:00 | |||
PLENARY 09.00 – 09.50 Chair: Dr. Colin Ruscoe, BCPC Anticipatory Governance and Responsible Innovation: “Newspeak” and the political control of technology Professor Joyce Tait, ESRC Innogen Institute, The University of Edinburgh |
|||
Stream A (Legal issues) Chair: Lucy Croucher, JSC International Limited |
Stream B (Human health) Chair: Dr. Manoj Aggarwal, Dow AgroSciences |
||
10.00 – 10.30 | Legal highlights of 2014 Claudio Mereu, fieldfisher |
10.00 – 10.30 | Cumulative risk assessment Dr. Stephanie Melching-Kollmuß, BASF SE |
Break 10.30 – 11.00 | |||
11.00 – 11.30 | Data confidentiality and the glyphosate issue Darren Abrahams, Steptoe & Johnson LLP |
11.00 – 11.30 | Challenging the reliability of conservative default dermal absorption with in vitro data Dr. Manoj Aggarwal, Dow AgroSciences |
11.30 – 11.45 | Q&A | 11.30 – 11.45 | Q&A |
Lunch 11.45 – 12.45 | |||
Stream A (Regulatory) Chair: Rob Mason Exponent International Limited |
Stream B (Efficacy) Chair: Sue Mattock, Chemicals Regulation Directorate, Health and Safety Executive |
||
12.45 – 13.15 | EU Regulation 1107/2009: Developments in the Annex I Renewal Process and Article 43 Dr. Michael Carroll, Dow AgroSciences |
12.45 – 13.15 | Rationalising efficacy requirements Sue Mattock, Chemicals Regulation Directorate, Health and Safety Executive |
13.15 – 13.45 | Candidates for Substitution and Comparative Assessment Janet Williams, Bayer CropScience Ltd |
13.15 – 13.45 | Efficacy Dr. Udo Heimbach, Julius Kühn Institut (JKI) |
13.45 – 14.00 | Q&A | 13.45 – 14.00 | Q&A |
Break 14.00 – 14.30 | |||
PLENARY Chair: Dr. Michael Carroll, Dow AgroSciences |
|||
14.30 – 15.00 | The consequences of regulating co-formulants Christopher Dobe, Syngenta Ltd |
||
15.00 – 15.30 | Basic and low risk substance regulation Hanneke Westland-Kaijser, Ctgb |
||
15.30 – 15.45 | Q&A | ||
15.45 – 16.00 | Close of Congress from the BCPC Chairman, Dr. Colin Ruscoe |